Results 11 to 20 of about 36,879 (249)

Risk of venous thromboembolic complications in patients with diabetes mellitus and COVID-19 [PDF]

open access: yesВестник медицинского института «Реавиз»: Реабилитация, врач и здоровье, 2023
The article assesses concomitant diabetes mellitus as a risk factor for venous thromboembolic complications in patients with covid-19 in hospital settings. We analyzed 123 case histories of patients hospitalized for new coronavirus infection in the first
D. V. Abramov, A. V. Smol'kina
doaj   +3 more sources

PREVENTION OF VENOUS THROMBOEMBOLIC COMPLICATIONS IN TRAUMAS OF LOCOMOTOR SYSTEM [PDF]

open access: yesМедицинский совет, 2016
Therapy of patients with disturbances of the locomotor system requires use of drugs to prevent venous thromboembolic complications. In addition to non-drug measures low-molecular heparins are the drugs of choice among coagulants at conservative therapy ...
S. S. KOPENKIN
doaj   +3 more sources

PREVENTION OF VENOUS THROMBOEMBOLIC COMPLICATIONS IN PRIMARY CARE [PDF]

open access: yesМедицинский совет, 2017
Venous thromboembolic complications remain a widespread cause of mortality and disability in hospitalized patients both in surgery and primary care all over the world, despite the fact that medical and mechanical methods of prevention have been known for
N. A. Novikova, A. S. Shilova
doaj   +3 more sources

Modern low-molecular-weight heparins in the prevention and treatment of venous thromboembolic complications in oncourologic patients [PDF]

open access: yesМедицинский совет, 2018
Oncourologic diseases are accompanied by a risk for subsequent venous thromboembolic complications, which are rated the most dangerous in terms of thrombogenic effect.
N. V. Vorobyev, S. V. Popov
doaj   +3 more sources

Risk of postoperative venous thromboembolic complication development in elderly patients [PDF]

open access: yesБюллетень сибирской медицины, 2018
Aim. To evaluate venous thromboembolic complication risk in elderly patients admitted to trauma and orthopedics departments, prevalence of comorbidity, its impact on the risk of thrombotic events, efficacy and safety of prophylactic anticoagulant therapy.
N. M. Krasnova   +3 more
doaj   +2 more sources

ANTICOAGULANT THERAPY OF VENOUS THROMBOEMBOLIC COMPLICATIONS: PROBLEMS AND PERSPECTIVES [PDF]

open access: yesРоссийский кардиологический журнал, 2015
The review takes into consideration the problems of effectiveness and safety of anticoagulant therapy in patients with venous thromboembolic complications. together with literature data we provide the results of our own study of optimization of long-term
N. M. Vorobieva, E. P. Panchenko
doaj   +3 more sources

Treatment of patients with ankle fractures. Use of Xarelto for the prevention of thromboembolic complications [PDF]

open access: yesМедицинский совет, 2014
The article tells about the results of analysis of treatment applied to patients with distal tibia fractures (transsyndesmotic malleolar fractures, 44-B type by AO classification, associated with rupture of the distal tibiofibular syndesmosis) and ...
AV Korolev   +4 more
doaj   +2 more sources

Prevention of venous thromboembolic complications in obstetrics and gynecology [PDF]

open access: yesМедицинский совет, 2018
Venous thromboembolic complications (VTEC) manifested as pulmonary embolism (PE) or deep vein thrombosis (DVT) are a serious and potentially fatal disease.
N. P. Shen
doaj   +3 more sources

Venous Thromboembolic Complications in Patients with Acute Chemical Poisoning [PDF]

open access: yesНеотложная медицинская помощь
RELEVANCE. Venous thromboembolic complications (VTEC) occur in patients hospitalized with various pathologies, complicate treatment and increase mortality. This problem has not received enough attention in toxicology.AIM OF THE STUDY. Conduct an analysis
M. V. Belova   +6 more
doaj   +2 more sources

DABIGATRAN ETEXILATE FOR THE TREATMENT OF VENOUS THROMBOEMBOLIC COMPLICATIONS [PDF]

open access: yesАтеротромбоз, 2015
This article discusses the significant features and use of new oral anticoagulant dabigatran etexilate for the treatment of venous thromboembolic complications (VTC).
N. M. Vorobieva, E. P. Panchenko
doaj   +2 more sources

Home - About - Disclaimer - Privacy